Ortin Global Ltd

Ortin Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Ortin Global Ltd

₹ 14.8 -0.67%
24 Jul - close price
ortinlabsindia.com BSE: 539287 NSE: ORTINGLOBE
About

Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.[1]

Key Points

Business Overview:[1]
OLL is engaged in the manufacturing and trading of pharmaceuticals, drugs, and Intermediates and is also engaged in real estate.

Website BSE NSE - BE
  • Market Cap ₹ 12.0 Cr.
  • Current Price ₹ 14.8
  • High / Low ₹ 21.3 / 10.7
  • Stock P/E
  • Book Value ₹
  • Dividend Yield 0.00 %
  • ROCE %
  • ROE %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Promoter holding is low: 1.23%
  • Promoter holding has decreased over last 3 years: -6.13%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2011 Mar 2012 Jun 2012
19.81 19.77 15.93
17.13 20.77 13.85
Operating Profit 2.68 -1.00 2.08
OPM % 13.53% -5.06% 13.06%
0.01 0.19 0.03
Interest 0.55 0.98 1.12
Depreciation 0.34 0.39 0.33
Profit before tax 1.80 -2.18 0.66
Tax % 33.33% -11.93% 33.33%
1.20 -1.92 0.44
EPS in Rs 3.24 -1.14 0.26
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Dividend Payout %
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: %
Stock Price CAGR
10 Years: -4%
5 Years: -15%
3 Years: -10%
1 Year: 21%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: %

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Equity Capital
Reserves
Total Liabilities
CWIP
Investments
Total Assets

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Net Cash Flow
Free Cash Flow
CFO/OP

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Debtor Days
Inventory Days
Days Payable
Cash Conversion Cycle
Working Capital Days
ROCE %

Insights

In beta
Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Number of operating manufacturing units
units ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Number of employees on rolls
employees ・Standalone data
Top product contribution to total turnover
% of turnover ・Standalone data
Manufacturing share of total revenue
% of revenue ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
7.37% 7.36% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23% 1.23%
0.00% 0.00% 0.00% 6.25% 6.25% 6.25% 6.53% 6.53% 1.68% 1.68% 1.68% 1.80%
92.64% 92.64% 98.76% 92.53% 92.52% 92.52% 92.24% 92.24% 97.08% 97.09% 97.10% 96.96%
No. of Shareholders 11,83612,31412,19211,95212,16512,09412,14412,03412,06011,83411,45211,383

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports